The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?

Curr Opin Endocrinol Diabetes Obes

Oregon Health & Science University, Division of Endocrinology, Diabetes, and Clinical Nutrition, Portland, Oregon, USA.

Published: August 2022

Purpose Of Review: The 1 mg overnight dexamethasone suppression test (ONDST) with a cutoff cortisol value of 1.8 mcg/dl (50 nmol/l) is routinely used for the assessment of incidental, benign adrenal nodules. Patients with an abnormal test are diagnosed with mild autonomous cortisol secretion (MACS). This timely commentary reviews the origins of the ONDST, its relationship to the diagnoses of MACS, and whether this is clinically relevant for clinical care.

Recent Findings: Millions of incidental adrenal nodules are found on CT scans annually. Several papers in the last three years discuss and advocate for the diagnose of MACS via the ONDST.

Summary: An ONDST cutoff of 1.8 mcg/dl (50 nmol/l) in patients with no clinical features of Cushing's syndrome will produce false positive results and a diagnosis of MACS that could result in unnecessary adrenalectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MED.0000000000000752DOI Listing

Publication Analysis

Top Keywords

overnight dexamethasone
8
dexamethasone suppression
8
suppression test
8
ondst cutoff
8
18 mcg/dl 50 nmol/l
8
adrenal nodules
8
test danger
4
danger adrenal
4
adrenal gland?
4
gland? purpose
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!